InforCapital
Startup Fundraising

WHOOP Raises $575M, Hits $10.1B Valuation

Wearable tech leader WHOOP closes $575M Series G at $10.1B valuation, fueled by celebrity investors and institutional capital for global health platform expansion.

AM
Alvaro de la Maza

Partner at Aninver

Key Takeaways

  • WHOOP raised $575.0M (Series G) from Collaborative Fund, 2PointZero Group, Qatar Investment Authority, Mubadala Investment, Abbott, Mayo Clinic, Macquarie Capital, Glade Brook, B-FLEXION, IVP, Foundry, Accomplice, Affinity Partners, Bullhound Capital.
  • Sector: Healthcare, Healthtech & Medtech, Technology, Software & Gaming, Consumer.
  • Geography: United States.

Analysis

WHOOP, the performance and health monitoring wearable company, has successfully closed a substantial Series G funding round, bringing in $575 million and achieving a commanding valuation of $10.1 billion. This significant capital infusion is earmarked to fuel the company's aggressive global expansion strategy and solidify its vision for a future centered on proactive, personalized health management.

The investment round saw participation from a notable roster of individual investors, including global sports and cultural icons such as Cristiano Ronaldo, LeBron James, Rory McIlroy, Reggie Miller, Niall Horan, Karen Wazen, Virgil van Dijk, and Shane Lowry. Their involvement highlights the deep synergy between WHOOP's mission and the pursuit of peak human performance and well-being.

This funding arrives at a critical juncture for preventative health. With chronic diseases on the rise and traditional healthcare models often focused on reactive treatment, the convergence of advanced AI and continuous biometric data offers a paradigm shift. WHOOP has spent over a decade cultivating its platform, which leverages over 24 billion hours of physiological data to power AI models that deliver predictive health insights. The company's app engagement, with members checking in an average of over eight times daily, far surpasses that of other screenless wearables, underscoring its utility in tracking sleep, recovery, and exertion.

The Series G round was spearheaded by Collaborative Fund, with significant contributions from a diverse group of sophisticated investors. These include 2PointZero Group, Qatar Investment Authority (QIA), Mubadala Investment Company, Abbott, Mayo Clinic, entities administered by Macquarie Capital, Glade Brook, B-Flexion, IVP, Foundry, Accomplice, Affinity Partners, and Bullhound Capital. This broad investor base reflects strong confidence in WHOOP's market position and future trajectory.

Will Ahmed, Founder and CEO of WHOOP, emphasized the collective mission driving the investment: “Our raise brings together the world’s most sophisticated investors, leading health institutions, and iconic global athletes behind the mission to unlock human performance and health span. We are building the personal health platform that people use to improve their health and livelihood.” The company's commitment to scaling its platform as a new benchmark for personalized, preventive healthcare is a key driver of this growth.

WHOOP has demonstrated impressive commercial traction, surpassing 2.5 million members globally. In the past year, bookings more than doubled, achieving 103% year-over-year growth and concluding the year with a $1.1 billion run rate. Crucially, the company achieved cash flow positivity in the same period, signaling a robust transition towards sustainable business operations. To support its ambitious expansion plans across the US, Europe, the Gulf Cooperation Council, Latin America, and Asia, WHOOP is actively recruiting for over 600 new roles, with a strong focus on research and development.